Mukhtarova, Liliya A.,
Fedorova, Yulia Yu.,
Karunas, Aleksandra S.,
Prokofyeva, Darya S.,
Nurgalieva, Alfia Kh.,
Khusnutdinova, Elza K.,
Zagidullin, Shamil Z. (2023) factors for
re-exacerbation and death from BA were identified. © 2023, Russian Open Medical Journal.
Sufianov, Albert,
Beilerli, Aferin,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Wenjie, Bu,
Beylerli, Ozal (2023) of therapeutic biomolecules to their target is a
challenging issue, which can be solved by innovations in drug
Chen, P.,
Yu, Y.,
Su, S.,
Du, Z.,
Cai, B.,
Sun, X.,
Chattipakorn, N.,
Samorodov, A.V.,
Pavlov, V.N.,
Tang, Q.,
Cho, W.-J.,
Liang, G. (2023) in lipopolysaccharide (LPS)-
challenged J774A.1 cells. Compounds 19, 20, and 39 potently reduced the release of IL-6
Zhiyong, Ji,
Yeping, Ling,
Pingbo, Chen,
Meng, Yuxiao,
Xu, Shancai,
Wu, Pei,
Wang, Chunlei,
Ilyasova, Tatiana,
Sun, Bowen,
Shi, Huaizhang (2023) of recurrent
serious ischemic events despite standard medical therapy, has been clinically
challenging. A
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Holz, Frank G.,
Panda-Jonas, Songhomitra,
Gilemzianova, Leisan I.,
Khakimov, Dinar A.,
Jonas, Jost B. (2023) number: DRKS00027302. © Author(s) (or their employer(s)) 2023. No commercial
re-use. See rights
Khidiyatova, Irina,
Khidiyatova, Indira,
Zinchenko, Rena,
Marakhonov, Andrey,
Karunas, Alexandra,
Avkhadeeva, Svetlana,
Aznzbaev, Marat,
Khusnutdinova, Elza (2023) pose
challenges for early DNA diagnosis. To comprehensively address this problem, it is essential